COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2016

Jan 27, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2016-01-22

Reporting Person: Schroeder Theodore R (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-22	Stock Option (Right to Purchase)	$17.06	A	15000	Acquired	2026-01-22	Common Stock (15000)	Direct

Footnotes

F1: The option vests and becomes exercisable over a four-year period commencing on January 22, 2016. Twenty-five percent (25%) of the option vests and becomes exercisable on January 22, 2017, and the balance vests in equal monthly installments (rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the director's continued service with the issuer.